Scoggin Management’s GeneDx Holdings WGS Stock Holding History

Scoggin Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,273	Closed	-$154K	–	66
2022 Q1	$230K	Buy	+2,273	New	+$253K	0.06%	43

Other funds holding WGS

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Scoggin Management's WGS Position: Q2 2022 in Review

Scoggin Management sold out of GeneDx Holdings (WGS) in Q2 2022, closing a stake of 2,273 shares — an estimated $154K sold.

Scoggin Management first reported a position in WGS in Q1 2022 and held it in 1 quarter. The position peaked at $230K in Q1 2022. 111 funds tracked by Wall St. Rank hold WGS as of Q2 2022.

Scoggin Management reported no remaining GeneDx Holdings position as of Q2 2022 after selling out during the quarter.
Scoggin Management sold 2,273 GeneDx Holdings shares in Q2 2022, an estimated $154K.
Scoggin Management first reported a position in GeneDx Holdings in Q1 2022 and held it in 1 quarter.
Scoggin Management's GeneDx Holdings position peaked at $230K in Q1 2022.
111 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2022.

Based on Scoggin Management's 13F filing for Q2 2022, filed 12 Aug 2022.